Sofinnova Management VIII

Latest statistics and disclosures from Sofinnova Management VIII's latest quarterly 13F-HR filing:

Companies in the Sofinnova Management VIII portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Spark Therapeutics 26.16 481270 -30% 89.16
Aclaris Therapeutics 24.23 1.54M 25.81
Obseva Sa 18.61 3.75M 8.14
Natera 12.18 1.55M 12.89
Nucana Plc american depositary shares 7.47 666666 NEW 18.37
Synlogic, Inc. 4.93 424972 NEW 19.02
Auris Med Hldg Ag 3.91 7.82M 0.82
Histogenics Corp Cmn 2.51 2.08M 1.98

Past 13F-HR SEC Filings by Sofinnova Management VIII

View All Filings